GENETICALLY ENGINEERED CO-EXPRESSION DNA VACCINES, CONSTRUCTION METHODS AND USES THEREOF

The present invention relates to co-expression DNA vaccines and methods for vaccinating animals against viral, bacterial and parasitic pathogens. In particular, the present invention relates to DNA vaccines that co-express antigens in combination with biologically-active components, such as adjuvant...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	AGWALE, SIMON, LEWIS, GEORGE, OBRIECHT, CHRISTINE, SHATA, MT, HONE, DAVID, FOUTS, TIMOTHY, BAGLEY, KEN, BOYSON, MICHAEL
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to co-expression DNA vaccines and methods for vaccinating animals against viral, bacterial and parasitic pathogens. In particular, the present invention relates to DNA vaccines that co-express antigens in combination with biologically-active components, such as adjuvants, immunoregulatory agents, antisense RNAs, and/or catalytic RNAs. L'invention concerne des vaccins à base d'ADN à co-expression et des procédés pour la vaccination d'animaux contre des agents pathogènes viraux, bactériens et parasites. L'invention concerne notamment des vaccins à base d'ADN qui co-expriment des antigènes en combinaison avec des composants actifs biologiquement, tels que des adjuvants, des agents immunorégulateurs, des ARN antisens ou des ARN catalytiques.